Yes, but carry a copy of your prescription and a letter from your doctor describing the medication. Some countries may require proof of medication for customs, and you should keep the tablets in their original packaging to avoid confusion.
Azathioprine is not typically screened for in routine occupational drug tests. However, because it is an immunosuppressant, you should disclose its use if the employer requires a health-related assessment.
In the UK, 25 mg tablets often bear the imprint “AZ 25” while 50 mg tablets may show “AZ 50”. Imprints can vary between manufacturers, so verify the appearance against the pharmacy label.
Both contain the same active ingredient and are required to meet identical bio-equivalence standards. Inactive ingredients such as fillers or dyes may differ slightly, which can affect tolerability in sensitive individuals.
Clinical improvement generally appears after 4-8 weeks of consistent therapy, though some patients may notice symptom relief earlier. Ongoing monitoring is essential to assess response.
Most vitamins are safe, but high-dose folic acid may mask early signs of bone-marrow suppression. Discuss any supplements with your healthcare provider to avoid unintended interactions.
Live vaccines are contraindicated, but the approved mRNA and adenoviral COVID-19 vaccines are not live and can be administered. Timing should be coordinated with your physician, especially if you have low white-blood-cell counts.
Contact your prescriber. Depending on the length of the gap and your blood-test results, the doctor may advise restarting at a lower dose or implementing alternative therapy.
Azathioprine is a small-molecule drug and is generally less expensive than biologic therapies such as monoclonal antibodies. Pricing varies by pharmacy and NHS formularies, but the lower cost is a factor in its continued use for many autoimmune conditions.
Azathioprine is an immunosuppressive medication classified under Autoimmune Care. It is available as a pill in strengths of 25 mg and 50 mg. In the UK, azathioprine is a prescription-only (POM) drug regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). It is marketed under several brand names, including Imuran and Azasan, but the active component in all formulations is azathioprine itself.
Azathioprine is a pro-drug that is converted inside cells to 6-mercaptopurine (6-MP) and then to active thioguanine nucleotides. These metabolites interfere with the synthesis of purine nucleotides, which are essential building blocks of DNA and RNA. By inhibiting purine synthesis, azathioprine reduces the proliferation of rapidly dividing immune cells-particularly T and B lymphocytes.
Through this mechanism, azathioprine helps control the inappropriate immune responses that drive autoimmune diseases and prevents rejection of transplanted organs.
Azathioprine is licensed in the United Kingdom for the following indications:
These uses are supported by regulatory approval from the MHRA and are reflected in the product’s Summary of Product Characteristics (SPC).
Azathioprine is sometimes employed for conditions that are not listed on the UK licence but have supporting clinical evidence:
Disclaimer: Off-label use of azathioprine requires careful risk-benefit assessment by a qualified healthcare professional and should be monitored closely for adverse effects.
General Advice: Always disclose the full list of medications, supplements, and herbal products to your prescriber before initiating azathioprine.
This article provides educational information about azathioprine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
